Dino Alberico

USPTO Granted Patents = 8 (Patent Applications = 3)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 5(Granted Patents)

Company Filing History:

6 out of 18

Alphora Research Inc.

patents

1 out of 35

Aerpio Therapeutics, Inc.

Years Active: 2011-2017

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9850254 - [object Object] (2017-12-26),

2. 9403864 - Process for the synthesis of carbonucleoside and intermediates for use therein (2016-08-02),

3. 9388135 - Process for preparing N-benzyl-3-hydroxy-4-substituted-pyridin-2-(1H)-ones (2016-07-12),

4. 9062020 - 2-((2S,3S,4R,5R)-5-((S)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation (2015-06-23),

5. 8658792 - Carbanucleoside synthesis and novel intermediate compounds useful therein (2014-02-25),

6. 8513441 - Prostaglandin synthesis and intermediates for use therein (2013-08-20),

7. 8309744 - Prostaglandin synthesis and intermediates for use therein (2012-11-13),

8. 7928252 - Prostaglandin synthesis and intermediates for use therein (2011-04-19),

Title: The Innovative Contributions of Dino Alberico

Introduction

Dino Alberico is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work focuses on the development of novel compounds and processes that have the potential to impact medical treatments.

Latest Patents

One of Alberico's latest patents involves a compound of formula 1, or a pharmaceutically acceptable salt thereof. This compound can be utilized in the preparation of halichondrin analogs, such as Eribulin. The patent also discloses a process for the preparation of this compound and the intermediates used in its synthesis. Another recent patent details a process for synthesizing a carbonucleoside of formula (1) and the intermediates required for this process. This method includes a Mitsunobu-type reaction to obtain a compound of formula (4), which is then deprotected to yield the final product.

Career Highlights

Throughout his career, Dino Alberico has worked with prominent companies in the pharmaceutical industry, including Alphora Research Inc. and Aerpio Therapeutics, Inc. His expertise in the field has allowed him to contribute to various innovative projects and advancements.

Collaborations

Alberico has collaborated with several professionals in his field, including Boris Gorin and Joshua Clayton. These partnerships have further enhanced his research and development efforts.

Conclusion

Dino Alberico's contributions to the field of pharmaceuticals through his patents and collaborations highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.